NCT01790282View on ClinicalTrials.gov

Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCT

NACompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

March 31, 2015

Conditions
IVFInfertility
Interventions
DRUG

estradiol plus progesterone 100 mg IM injection

estradile valaerate 2mg plus progesterone 100 mg/day support arm :E2 valerate 2mg three times /day are given to the arm cases plus P4 100 IM/day for 14 days starting on day of ovum pickup and single IM injection of 0.1 mg decapeptyl on day of ET

DRUG

Progesterone IM of 100 mg

Starting on day of ovum pickup ICSI cases are given prontogest 100 mg IM /day plus single dose dose of treptorline 0.1mg is given sc on day of embryo transfer

Trial Locations (1)

Unknown

Mansoura Integrated fertility center, Al Mansurah

All Listed Sponsors
lead

Mansoura Integrated Fertility Center

OTHER

NCT01790282 - Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCT | Biotech Hunter | Biotech Hunter